Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

DIRECTOR DEALINGS: AstraZeneca Director Buys American Depositary Shares

10th Feb 2014 17:34

LONDON (Alliance News) - AstraZeneca PLC said Monday that Director Bruce Burlington bought 500 American Depositary Shares at USD62.92 each last Friday. Following this purchase Burlington has 2,053 shares in AstraZeneca. Shares in AstraZeneca closed up 1.1% at 3,902.02 pence Monday aft Read More

UK BROKER RATINGS: Goldman Sachs Initiates Vodafone With Buy Rating

10th Feb 2014 10:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />GOLDMAN STARTS VODAFONE WITH 'BUY' - PRICE TARGET 275 PENCE <br />----------<br />MORGAN STANLEY RAISES ASTRAZENECA PRICE TARGET Read More

MARKET COMMENT: FTSE 100 Snaps Two Week Losing Streak

7th Feb 2014 17:38

LONDON (Alliance News) - UK stocks closed higher Friday, and for the week as a whole, despite the much-anticipated US non-farm payrolls reported coming in much worse-than-expected. Meanwhile, it was a volatile day in the forex market as both the pound and the euro fell against the US dollar Read More

DIRECTOR DEALINGS: AstraZeneca Non-Executive Buys Shares

7th Feb 2014 15:41

LONDON (Alliance News) - AstraZeneca PLC said Friday that senior independent non-executive Director John Varley had bought 4,056 shares at 3,848 pence each. Following this transaction Varlet holds 9,500 shares in the company. Shares in the pharmaceutical company were trading up 0.9% a Read More

UK MIDDAY BRIEFING: Markets Up For A Third Day, US Jobs Data Eyed

7th Feb 2014 12:50

LONDON (Alliance News) - London's equity markets are up for a third consecutive day Friday as stocks around the world continue to take back some of the losses seen in the preceding five days, but this afternoon's US non-farm payrolls data will decide whether the gains are maintained.<br /><br Read More

UK WINNERS & LOSERS: AstraZeneca Recovers but Shire Slides

7th Feb 2014 11:02

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Tate & Lyle, up 2.2%. The speciality food and bulk ingredients manufacturer has jumped after JPMorgan Cazenove upgraded its r Read More

UK BROKER RATINGS: Liberum Raises AstraZeneca To Top Pick

7th Feb 2014 10:04

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />S&amp;P CAPITAL IQ RAISES ASTRAZENECA PRICE TARGET TO 3800 (3700) PENCE - 'HOLD' <br />----------<br />SO Read More

UK MORNING BRIEFING: Shares Gain; AstraZeneca Is Conviction Buy

7th Feb 2014 08:20

LONDON (Alliance News) - UK shares have opened higher Friday, as the market looks ahead positively to the US non-farm payrolls report later in the day.<br /><br />After its results on Thursday, <strong>AstraZeneca</strong> has been named a Conviction Buy by Liberum. Meanwhile, JPMorgan has lif Read More

MARKET COMMENT: Few Decliners On FTSE 100 As Global Stocks Rally

6th Feb 2014 17:13

LONDON (Alliance News) - Global stocks indices rallied Thursday, with only a handful of FTSE 100 companies closing lower, as the UK and European Central Banks kept their monetary policies unchanged and US economic data continued to improve ahead of Fridays key jobs report.<br /><br />The FTSE Read More

2nd UPDATE: AstraZeneca 2013 Results Down, Guidance Lowered

6th Feb 2014 13:31

LONDON (Alliance News) - AstraZeneca PLC lowered its full-year forecast Thursday, as it saw revenue and pretax profit decline in the full year ended December 31, 2013, due to the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant p Read More

UK MIDDAY BRIEFING: Stocks Rising Again, Vodafone Leads FTSE 100

6th Feb 2014 13:18

LONDON (Alliance News) - The FTSE 100 is up for a second day Thursday as the rebound from the heavy losses in equity markets in the previous five days continues, with positive reports from the likes of <strong>Vodafone</strong> and <strong>Smith &amp; Nephew</strong> helping London's blue-chip Read More

UK WINNERS & LOSERS: EasyJet And TUI Travel In Different Directions

6th Feb 2014 11:45

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br /><br />-------<br /><br /><strong>FTSE 100 - WINNERS</strong><br /><br /><strong>Vodafone</strong>, up 2.9%. The telecommunications company has confirmed its ful Read More

TOP NEWS: Imagination Technologies Extends Apple Contract

6th Feb 2014 11:29

LONDON (Alliance News) - The following is a summary of top news stories Thursday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Vodafone</strong> Group PLC confirmed its full-year guidance, expecting an adjusted operating profit of around GBP5.0 billion, as it sa Read More

UPDATE: AstraZeneca 2013 Revenue, Profit Down On Loss Of Exclusivity

6th Feb 2014 11:10

LONDON (Alliance News) - AstraZeneca PLC said Thursday it saw revenue and pretax profit decline in the full year ended December 31, 2013, as it continued to be hit by the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant posted re Read More

MARKET COMMENT: UK Stocks Push Higher, Led By House Builders

6th Feb 2014 10:50

LONDON (Alliance News) - Stock markets have started strongly Thursday, with the FTSE 100 recording its best gains for many sessions, led higher by house builders after Halifax said UK house prices are rising faster than expected. Meanwhile the pound and the euro remain subdued ahead of the Read More

UPDATE: AstraZeneca 2013 Revenue, Profit Down On Loss Of Exclusivity

6th Feb 2014 10:32

LONDON (Alliance News) - AstraZeneca PLC said Thursday it saw revenue and pretax profit decline in the full year ended December 31, 2013, as it continued to be hit by the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant posted re Read More

UK MORNING BRIEFING: Vodafone Gains, AstraZeneca Falls At Open

6th Feb 2014 08:32

LONDON (Alliance News) - <strong>Vodafone</strong> has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%. <br /><br />Meanwhile, <strong>AstraZeneca</strong> has opened down 2.1% after reporting lower revenue and profit Read More

UK MORNING BRIEFING:

6th Feb 2014 08:31

LONDON (Alliance News) - <strong>Vodafone</strong> has delivered results in line with expectations Thursday morning, helping to give UK share a positive start. Vodafone is up 1.4%. <br /><br />Meanwhile, <strong>AstraZeneca</strong> has opened down 2.1% after reporting lower revenue and profit Read More

AstraZeneca 2013 Revenue, Pretax Profit Down On Loss Of Exclusivity

6th Feb 2014 07:43

LONDON (Alliance News) - AstraZeneca PLC said Thursday it saw revenue and pretax profit decline in the full year ended December 31, 2013, as it continued to be hit by the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant posted re Read More

MARKET COMMENT: UK Stocks Called Higher Ahead Of Rate Decisions

6th Feb 2014 07:38

LONDON (Alliance News) - UK stocks are called to open marginally higher Wednesday, shrugging off a lower close on Wall Street overnight, as investors await interest rate decisions from both the UK and the eurozone. Meanwhile, market participants in London face another day of transport disru Read More

FTSE 100 Latest
Value10,138.09
Change0.00